Amy Wilson-O'Brien

University of Melbourne

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (18)

Collaborators (5)

Michael A. Kamm

Olga Niewiadomski

University of Melbourne

Mark Morrison

University of Queensland

Erin Russell

University of Melbourne

seungha kang

University of Queensland

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Amy Wilson-O'Brien

Research Interests

Explore related searches

Contact this professor

Articles (18)

Collaborators (5)

Michael A. Kamm

Olga Niewiadomski

Mark Morrison

Erin Russell

seungha kang

Make your next move.

Amy Wilson-O'Brien

Research Interests

Explore related searches

Contact this professor

Articles (18)

Practical Application of Evidence-Based Dietary Therapy in Inflammatory Bowel Disease: The DELECTABLE Program

1330: PROTEUS MIRABILIS PROMOTES POSTOPERATIVE RECURRENCE OF CROHN’S DISEASE THROUGH LYMPHATIC TRANSLOCATION AND ABERRANT IMMUNE ACTIVATION ELICITED BY INTESTINAL RECOLONIZATION

555: DEVELOPMENT OF A RATIONALLY DESIGNED BACTERIAL CONSORTIUM THAT CAN RESTORE GUT HOMEOSTASIS AND IMPROVE THERAPEUTIC RESPONSE IN CROHN’S DISEASE

Su1973: FUNCTIONAL AND TAXONOMIC BIOMARKERS OF CROHN’S DISEASE AND HEALTH FROM THE COLONIC MUCOSA-ASSOCIATED MICROBIOTA. THE ENIGMA STUDY.

Faecal microbiota transplantation in Crohn's disease: an Australian randomised placebo-controlled trial protocol

Noninvasive, microbiome-based diagnosis of inflammatory bowel disease

Sa1856 CROHN'S DISEASE MUCOSAL MICROBIOTA VIRULENCE FACTOR GENE ANALYSIS IDENTIFIES ANTIBIOTIC RESISTANT ENTEROCOCCUS FAECALIS LINKED TO IMMUNE ACTIVATION. THE ENIGMA STUDY

Sa1857 THE KEY ANTI-INFLAMMATORY BACTERIUM FAECALIBACTERIUM PRAUSNITZII IS MORE COMPLEX AND DIVERSE THAN PREVIOUSLY RECOGNISED: ANATOMIC, GEOGRAPHIC, AND GENOMIC DIFFERENCES IN THE EAST AND WEST AND IN HEALTH AND CROHN'S DISEASE. THE ENIGMA STUDY.

Effect of food additives on key bacterial taxa and the mucosa-associated microbiota in Crohn’s disease. The ENIGMA study

Mo1717 PRACTICAL APPLICATION OF EVIDENCE-BASED DIETARY THERAPY INTO INFLAMMATORY BOWEL DISEASE CARE SHOWS HIGH PATIENT SATISFACTION, COMPLIANCE, AND EFFICIENCY. THE DELECTABLE PROGRAM.

Mo1807 THE SECRETOMES OF COLONIC MUCOSA-ASSOCIATED MICROBIOTA IN CROHN'S DISEASE AND HEALTH IDENTIFY KEY BACTERIA DRIVING PRO- AND ANTI-INFLAMMATORY RESPONSES. THE ENIGMA STUDY.

Mo1811 CHARACTERIZATION OF THE KEY ANTI-INFLAMMATORY BACTERIUM FAECALIBACTERIUM PRAUSNITZII INTERNATIONALLY IN HEALTH AND CROHN'S DISEASE. THE ENIGMA STUDY.

Mo1815 CHARACTERIZATION OF THE COLONIC MUCOSA-ASSOCIATED METAGENOME REVEALS NOVEL MICROBES AND GEOGRAPHICALLY DISTINCT COMMUNITIES IN HEALTH AND CROHN'S DISEASE. THE ENIGMA STUDY.

DOP48 Key Anti-Inflammatory Faecalibacterium prausnitzii is Heterogeneous and Diverse in the East and West and in Health and Crohn’s disease. The ENIGMA study

DOP49 Metagenomic Characterisation of The Colonic Mucosa-Associated Microbiota Reveals Novel Microbes and Communities in Health and Crohn’s disease. The ENIGMA study

P766 Practical application of evidence-based dietary therapy into inflammatory bowel disease care shows high patient satisfaction, compliance, and efficacy. The Delectable Program

P925 Deep functional assessment of the colonic mucosa-associated microbiota in Crohn's disease and health identifies pro- and anti- inflammatory secretomes and associated bacterial consortia. The ENIGMA study

Clinical outcomes amongst elderly patients with inflammatory bowel disease

Collaborators (5)

Michael A. Kamm

Olga Niewiadomski

Mark Morrison

Erin Russell

seungha kang

Make your next move.